Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 08:19 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 11,430,455 7.390% | -3,125,100![]() (-21.47%) | Filing History |
| 2026-05-15 08:18 am Sale | 2026-03-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Avoro Capital Advisors LLC | 2,300,000 4.450% | -600,000![]() (-20.69%) | Filing History |
| 2026-05-15 08:17 am Purchase | 2026-03-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 5,777,777 6.260% | 111,111![]() (+1.96%) | Filing History |
| 2026-05-15 08:16 am Purchase | 2026-03-31 | 13G | DAMORA THERAPEUTICS, INC DMRA | Avoro Capital Advisors LLC | 3,783,000 6.270% | 3,783,000![]() (New Position) | Filing History |
| 2026-05-15 08:15 am Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Avoro Capital Advisors LLC | 1,410,000 5.750% | 1,410,000![]() (New Position) | Filing History |
| 2026-05-14 8:04 pm Purchase | 2026-05-12 | 13D | WHITEHAWK THERAPEUTICS, INC. C WHWK | Avoro Capital Advisors LLC | 18,292,675 19.990% | 6,377,714![]() (+53.53%) | Filing History |
| 2026-02-17 09:05 am Purchase | 2025-12-31 | 13G | UNIQURE N V QURE | Avoro Capital Advisors LLC | 6,150,000 9.870% | 2,525,000![]() (+69.66%) | Filing History |
| 2026-02-17 09:04 am Purchase | 2025-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 14,555,555 9.970% | 3,747,475![]() (+34.67%) | Filing History |
| 2026-02-17 09:03 am Sale | 2025-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | Avoro Capital Advisors LLC | 8,515,792 5.540% | -1,420,000![]() (-14.29%) | Filing History |
| 2026-02-17 09:02 am Purchase | 2025-12-31 | 13G | CELCUITY INC CELC | Avoro Capital Advisors LLC | 3,111,111 6.720% | 3,111,111![]() (New Position) | Filing History |
| 2026-02-17 09:01 am Purchase | 2025-12-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Avoro Capital Advisors LLC | 2,900,000 5.400% | 850,000![]() (+41.46%) | Filing History |
| 2026-02-17 09:00 am Purchase | 2025-12-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Avoro Capital Advisors LLC | 5,000,000 5.080% | 5,000,000![]() (New Position) | Filing History |
| 2025-11-14 09:07 am Sale | 2025-09-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 0 0.000% | -3,725,000![]() (Position Closed) | Filing History |
| 2025-11-14 09:06 am Sale | 2025-09-30 | 13G | AMICUS THERAPEUTICS INC FOLD | Avoro Capital Advisors LLC | 15,025,000 4.870% | -5,475,000![]() (-26.71%) | Filing History |
| 2025-11-14 09:05 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Avoro Capital Advisors LLC | 10,808,080 8.060% | 10,808,080![]() (New Position) | Filing History |
| 2025-11-14 09:03 am Sale | 2025-09-30 | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | Avoro Capital Advisors LLC | 2,000,000 3.150% | -2,150,000![]() (-51.81%) | Filing History |
| 2025-11-14 09:01 am Purchase | 2025-09-30 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Avoro Capital Advisors LLC | 16,216,665 9.380% | 16,216,665![]() (New Position) | Filing History |
| 2025-08-14 07:18 am Sale | 2025-06-30 | 13G | BLUEPRINT MEDICINES CORP COM BPMC | Avoro Capital Advisors LLC | 375,000 0.600% | -3,475,000![]() (-90.26%) | Filing History |
| 2025-08-14 07:13 am Sale | 2025-06-30 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Avoro Capital Advisors LLC | 2,050,000 4.100% | -131,000![]() (-6.01%) | Filing History |
| 2025-08-14 07:10 am Sale | 2025-06-30 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Avoro Capital Advisors LLC | 3,725,000 6.100% | -620,000![]() (-14.27%) | Filing History |

